These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 20460355
1. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia. Balci YI, Karabulut A, Kabukcu S, Sari I, Keskin A. Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355 [Abstract] [Full Text] [Related]
2. New Insights Into the Treatment of Glanzmann Thrombasthenia. Poon MC, Di Minno G, d'Oiron R, Zotz R. Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829 [Abstract] [Full Text] [Related]
3. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia]. Sugihara S, Katsutani S, Hyodo H, Hyodo M, Kudo Y, Fujii T, Kimura A. Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596 [Abstract] [Full Text] [Related]
4. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention. Poon MC, d'Oiron R, Zotz RB, Bindslev N, Di Minno MN, Di Minno G, Glanzmann Thrombasthenia Registry Investigators. Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792 [Abstract] [Full Text] [Related]
5. Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions. Devecioğlu O, Unüvar A, Anak S, Bilge I, Ander H, Ziylan O. Turk J Pediatr; 2003 Aug; 45(1):64-6. PubMed ID: 12718376 [Abstract] [Full Text] [Related]
6. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients. Levy-Mendelovich S, Levy T, Budnik I, Barg AA, Rosenberg N, Seligsohn U, Kenet G, Livnat T. Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506 [Abstract] [Full Text] [Related]
7. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Poon MC, Demers C, Jobin F, Wu JW. Blood; 1999 Dec 01; 94(11):3951-3. PubMed ID: 10572113 [Abstract] [Full Text] [Related]
8. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents. Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y. Semin Hematol; 2006 Jan 01; 43(1 Suppl 1):S33-6. PubMed ID: 16427383 [Abstract] [Full Text] [Related]
9. Use of rFVIIa in 4 children with Glanzmann thrombasthenia. Valentino LA. J Pediatr Hematol Oncol; 2006 Oct 01; 28(10):653-8. PubMed ID: 17023825 [Abstract] [Full Text] [Related]
10. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a. Hennewig U, Laws HJ, Eisert S, Göbel U. Klin Padiatr; 2005 Oct 01; 217(6):365-70. PubMed ID: 16307424 [Abstract] [Full Text] [Related]
11. Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy. Ogawa Y, Kunishima S, Yanagisawa K, Osaki Y, Uchiyama Y, Matsumoto N, Tokiniwa H, Horiguchi J, Nojima Y, Handa H. Int J Hematol; 2017 Feb 01; 105(2):221-225. PubMed ID: 27696190 [Abstract] [Full Text] [Related]
12. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature. Rajpurkar M, Chitlur M, Recht M, Cooper DL. Haemophilia; 2014 Jul 01; 20(4):464-71. PubMed ID: 24948404 [Abstract] [Full Text] [Related]
13. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia. Franchini M, Lippi G. Expert Rev Hematol; 2014 Dec 01; 7(6):733-40. PubMed ID: 25387838 [Abstract] [Full Text] [Related]
14. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. Poon MC, D'Oiron R, Von Depka M, Khair K, Négrier C, Karafoulidou A, Huth-Kuehne A, Morfini M, International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group. J Thromb Haemost; 2004 Jul 01; 2(7):1096-103. PubMed ID: 15219192 [Abstract] [Full Text] [Related]
15. Surgical resection of a sphenoid wing meningioma in a patient with Glanzmann thrombasthenia. Wertz D, Boveroux P, Péters P, Lenelle J, Franssen C. Acta Anaesthesiol Belg; 2011 Jul 01; 62(2):83-6. PubMed ID: 21919374 [Abstract] [Full Text] [Related]
16. [Use of recombinant factor VII in Glanzmann thrombasthenia: a case report]. Chabchoub Ben Abdallah R, Trabelsi L, Ben Ameur S, Kammoun F, Boukédi A, Ben Salah M, Ben Hlima N, Mahfoudh A. Arch Pediatr; 2010 Jul 01; 17(7):1062-4. PubMed ID: 20570498 [Abstract] [Full Text] [Related]
17. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry. Recht M, Rajpurkar M, Chitlur M, d'Oiron R, Zotz R, Di Minno G, Cooper DL, Poon MC. Am J Hematol; 2017 Jul 01; 92(7):646-652. PubMed ID: 28370369 [Abstract] [Full Text] [Related]
18. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia. van Buuren HR, Wielenga JJ. Dig Dis Sci; 2002 Sep 01; 47(9):2134-6. PubMed ID: 12353868 [Abstract] [Full Text] [Related]
20. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. Poon MC. Vasc Health Risk Manag; 2007 Sep 01; 3(5):655-64. PubMed ID: 18078017 [Abstract] [Full Text] [Related] Page: [Next] [New Search]